Russell Investments Group
NVO

Russell Investments Group’s Novo Nordisk NVO Stock Holding History

Russell Investments Group’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.5M Buy
219,072
+46,266
+27% +$1.99M 0.01% 1042
2026
Q1 		$6.35M Sell
172,806
-5,209
-3% -$247K 0.01% 1209
2025
Q4 		$9.06M Sell
178,015
-3,067
-2% -$157K 0.01% 974
2025
Q3 		$10M Buy
181,082
+18,371
+11% +$1.08M 0.01% 900
2025
Q2 		$11.2M Sell
162,711
-61,629
-27% -$4.19M 0.01% 791
2025
Q1 		$15.6M Sell
224,340
-426,323
-66% -$35.2M 0.02% 656
2024
Q4 		$56M Buy
650,663
+291,524
+81% +$31.5M 0.08% 271
2024
Q3 		$42.8M Sell
359,139
-15,922
-4% -$2.12M 0.06% 328
2024
Q2 		$53.6M Sell
375,061
-80,268
-18% -$10.6M 0.09% 241
2024
Q1 		$58.4M Buy
455,329
+301,361
+196% +$35.9M 0.09% 240
2023
Q4 		$15.9M Sell
153,968
-20,488
-12% -$2.03M 0.03% 592
2023
Q3 		$15.9M Sell
174,456
-42,778
-20% -$3.77M 0.03% 553
2023
Q2 		$17.6M Buy
217,234
+536
+0.2% +$43.8K 0.03% 534
2023
Q1 		$17.2M Buy
216,698
+23,926
+12% +$1.7M 0.03% 568
2022
Q4 		$13M Hold
192,772
– – 0.03% 665
2022
Q3 		$9.6M Sell
192,772
-103,204
-35% -$5.53M 0.02% 762
2022
Q2 		$16.5M Buy
295,976
+3,838
+1% +$213K 0.03% 578
2022
Q1 		$16.2M Hold
292,138
– – 0.03% 634
2021
Q4 		$16.4M Hold
292,138
– – 0.03% 679
2021
Q3 		$14M Sell
292,138
-260,892
-47% -$12.6M 0.02% 733
2021
Q2 		$23.2M Buy
553,030
+260,892
+89% +$10.1M 0.04% 544
2021
Q1 		$9.85M Hold
292,138
– – 0.02% 959
2020
Q4 		$10.2M Hold
292,138
– – 0.02% 843
2020
Q3 		$10.1M Hold
292,138
– – 0.02% 764
2020
Q2 		$9.56M Sell
292,138
-305,018
-51% -$9.73M 0.02% 756
2020
Q1 		$18M Sell
597,156
-277,728
-32% -$8.27M 0.05% 440
2019
Q4 		$25.3M Sell
874,884
-47,538
-5% -$1.32M 0.05% 450
2019
Q3 		$23.8M Sell
922,422
-8,702
-0.9% -$220K 0.05% 465
2019
Q2 		$23.8M Sell
931,124
-308,910
-25% -$7.63M 0.04% 483
2019
Q1 		$32.4M Buy
1,240,034
+276,990
+29% +$6.81M 0.06% 390
2018
Q4 		$22.2M Sell
963,044
-75,386
-7% -$1.68M 0.05% 447
2018
Q3 		$24.5M Sell
1,038,430
-228,862
-18% -$5.59M 0.05% 479
2018
Q2 		$29.2M Buy
1,267,292
+263,214
+26% +$6.26M 0.06% 374
2018
Q1 		$24.7M Buy
1,004,078
+6,530
+0.7% +$171K 0.04% 510
2017
Q4 		$26.8M Sell
997,548
-146,208
-13% -$3.72M 0.05% 500
2017
Q3 		$27.5M Sell
1,143,756
-88,248
-7% -$1.99M 0.05% 474
2017
Q2 		$26.4M Sell
1,232,004
-175,642
-12% -$3.54M 0.05% 489
2017
Q1 		$24.1M Buy
1,407,646
+146,426
+12% +$2.55M 0.04% 491
2016
Q4 		$22.6M Buy
+1,261,220
New +$22.9M 0.04% 496

Other funds holding NVO

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
MG
Markel Group Glen Allen, Virginia $13.1B AUM 15.62% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return

Russell Investments Group's NVO Position: Q2 2026 in Review

Russell Investments Group increased its Novo Nordisk (NVO) stake by 27% in Q2 2026, buying an estimated $1.99M and bringing the position to 219,072 shares worth $10.5M. The position accounts for 0.01% of the portfolio, ranked #1042.

Russell Investments Group first reported a position in NVO in Q4 2016 and has held it in 39 quarters since. The position peaked at $58.4M in Q1 2024. 819 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Russell Investments Group held 219,072 shares of Novo Nordisk worth $10.5M as of Q2 2026.
  • Russell Investments Group bought 46,266 Novo Nordisk shares in Q2 2026, an estimated $1.99M.
  • Novo Nordisk made up 0.01% of Russell Investments Group's portfolio in Q2 2026, its #1042 holding.
  • Russell Investments Group first reported a position in Novo Nordisk in Q4 2016 and has held it in 39 quarters since.
  • Russell Investments Group's Novo Nordisk position peaked at $58.4M in Q1 2024.
  • 819 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.